VTT and Dyadic International presenting excellent results reached in development of a new fungal production platform C1 for vaccines and therapeutic proteins

(VTT Technical Research Centre of Finland) VTT and Dyadic International, Inc. ('Dyadic') (OTCQX: DYAI), today announced that VTT scientists will present the excellent results in their collaboration over the past two years at two international conferences: AAPS PharmSci on November 7th in Washington DC and PEGS Europe on November 14th in Lisbon.
Source: EurekAlert! - Biology - Category: Biology Source Type: news